Search
Myomo Inc
MYOAdd to Watchlist
1.188USD
+0.128+12.10%
Market hours （ET）Quotes delayed by 15 min
45.83MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-08-05The current earnings forecast score of Myomo Inc is 8.00, ranking 65 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 4.00, with a high of 10.00 and a low of 2.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
4.420
Target Price
+337.62%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Myomo Inc
MYO
5
Stryker Corp
SYK
30
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Abbott Laboratories
ABT
29
Zimmer Biomet Holdings Inc
ZBH
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Myomo Inc's expected revenue for the next quarter?
Myomo Inc's expected revenue is 10.35M.
What is Myomo Inc's price target?
Analysts forecast that Myomo Inc's price target is USD 4.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 2.00.
How have Myomo IncMYO's recent earnings per share performed?
The market expectation was USD -0.07, while Myomo IncMYO's earnings per share (EPS) for the previous quarter was USD -0.09. EPS for the next quarter is expected at USD -0.10.
What is the analyst rating for Myomo Inc?
Based on the ratings of Myomo Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.